| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/05/2009 | WO2009026729A1 Amino acid pairing-based self assembling peptides and methods |
| 03/05/2009 | WO2009026697A1 A method of reducing a vasodilatory response using a guanylate cyclase pathway inhibitor or an h2o2 reducing agent |
| 03/05/2009 | WO2009026687A1 Neuroprotection using nap-like and sal-like peptide mimetics |
| 03/05/2009 | WO2009026622A1 Modulators of hypersensitivity reactions |
| 03/05/2009 | WO2009026614A1 Hypoglycaemic tripeptide and methods of use thereof |
| 03/05/2009 | WO2009007746A3 Treatment of sensorineural hearing loss |
| 03/05/2009 | WO2009006732A9 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 03/05/2009 | WO2009005877A3 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| 03/05/2009 | WO2009003694A3 Method for treating diseases related to mitochondrial dysfunction |
| 03/05/2009 | WO2009002824A3 A method to reduce citrus fruit peel pitting and delay senescence |
| 03/05/2009 | WO2008153705A3 Methods of treating, diagnosing and detecting fgf21-associated disorders |
| 03/05/2009 | WO2008152392A3 Use of beta-gbp (galactoside binding protein) |
| 03/05/2009 | WO2008151257A3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 03/05/2009 | WO2008145853A3 Use of an active ingredient derived from amaranth (amaranthus) for preparing a composition for activating cell energy and for protecting the skin against oxidative damage |
| 03/05/2009 | WO2008136820A8 Stabilization of mammalian membrane proteins by short surfactant peptides |
| 03/05/2009 | WO2008133961A3 Igf-1r binding proteins and antagonists |
| 03/05/2009 | WO2008133652A3 Binary epitope antibodies and b cell superantigen immune stimulants |
| 03/05/2009 | WO2008105791A3 Collagen scaffolds, medical implants with same and methods of use |
| 03/05/2009 | WO2008097541A3 Variants derived from actriib and uses therefor |
| 03/05/2009 | WO2008097536A3 Compositions and methods for treating psychiatric diseases and disorders |
| 03/05/2009 | WO2008035371A4 Dietary anti-bacterial compositions |
| 03/05/2009 | WO2007140284A4 N-terminally modified glp-1 receptor modulators |
| 03/05/2009 | WO2007126365A8 Further medical uses of antisecretory protein |
| 03/05/2009 | WO2007072037A9 Cyclic antimicrobial peptides |
| 03/05/2009 | WO2006137934A3 Purposeful movement of human migratory cells away from an agent source |
| 03/05/2009 | WO2006134340A9 Oxyntomodulin analogues and their effects on feeding behaviour |
| 03/05/2009 | WO2003048376A9 Modulation of immune-cell related disorders using il-1hy2 |
| 03/05/2009 | US20090064350 Detection and treatment of drug associated angioedema |
| 03/05/2009 | US20090062785 Compositions and methods for cancer treatment using targeted single-walled carbon nanotubes |
| 03/05/2009 | US20090062382 External preparation for improving coital function |
| 03/05/2009 | US20090062249 An intraocular, biodegradable drug delivery system comprising anecortave acetate and a biodegradable glycolic acid-lactic acid copolymer effective in releasing the immunosuppressant into the eye over a period of > 3 weeks; sustained release from a single pellet or a single extruded filament |
| 03/05/2009 | US20090062235 Inhibitors of Dipeptidylpeptidase IV |
| 03/05/2009 | US20090062213 Small Molecule Inhibitors of PDZ Interactions |
| 03/05/2009 | US20090062212 Peptide analogs that are potent and selective for human neurotensin preceptor subtype 2 |
| 03/05/2009 | US20090062211 Conopeptides and methods of use |
| 03/05/2009 | US20090062210 Methods for promoting erythropoiesis |
| 03/05/2009 | US20090062209 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 03/05/2009 | US20090062208 Methods for maintaining blood-brain barrier integrity in hypertensive subjects using a delta-PKC inhibitor |
| 03/05/2009 | US20090062207 Methods and compositions for the treatment of gastrointestinal disorders |
| 03/05/2009 | US20090062206 Urodilatin Cancer Treatment |
| 03/05/2009 | US20090062205 Reconstitution Medium For Protein and Peptide Formulations |
| 03/05/2009 | US20090062204 Compositions and methods for treating and preventing gastroenteric diseases |
| 03/05/2009 | US20090062203 Dipeptidyl peptidase iv inhibitors for the treatment of schizophrenia and depression |
| 03/05/2009 | US20090062202 Methods of treating and preventing pressure ulcers with intradermal and transdermal delivery of calcitonin gene-related peptide (cgrp) |
| 03/05/2009 | US20090062201 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 03/05/2009 | US20090062200 VEGF-Binding Fusion Proteins and Therapeutic Uses Thereof |
| 03/05/2009 | US20090062199 Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof |
| 03/05/2009 | US20090062198 Maurotoxin, PI1 and HSTX1 derivatives |
| 03/05/2009 | US20090062197 Sp1 Polypeptides, Modified Sp1 Polypeptides and Uses Thereof |
| 03/05/2009 | US20090062196 Compositions and methods of treating cancer |
| 03/05/2009 | US20090062195 Kallikrein-Inhibitor Therapies |
| 03/05/2009 | US20090062194 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/05/2009 | US20090062193 Compositions and methods for the control, prevention and treatment of obesity and eating disorders |
| 03/05/2009 | US20090062192 Dimeric Peptide Agonists of the Glp-1 Receptor |
| 03/05/2009 | US20090062191 Composition for maintaining gastrointestinal homeostasis |
| 03/05/2009 | US20090062190 Transcriptional Regulation of Cytokines by LITAF and STAT (6)(B) |
| 03/05/2009 | US20090062189 Tumor suppressor protein and nucleotide encoding same |
| 03/05/2009 | US20090062188 Disease-Associated Protein |
| 03/05/2009 | US20090062187 Use of Hmgb1 for Wound Healing |
| 03/05/2009 | US20090062186 Compounds Binding To P-Selectin |
| 03/05/2009 | US20090062185 Deuterium-enriched anidulafungin |
| 03/05/2009 | US20090062184 Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
| 03/05/2009 | US20090062183 Modulation of synaptogenesis |
| 03/05/2009 | US20090062182 Deuterium-enriched dalbavancin |
| 03/05/2009 | US20090062181 Mineral Collagen Chelates And Methods Of Making And Using Same |
| 03/05/2009 | US20090062180 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders |
| 03/05/2009 | US20090062179 determining whether a cancer cell is sensitive to endocrine therapy by detecting the presence of binding of Deleted in Breast Cancer-1 (DBC-1) and Estrogen Receptor alpha (ER alpha ) |
| 03/05/2009 | US20090062178 Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 03/05/2009 | US20090062150 Compositions and methods for regulating intramembrane proteases |
| 03/05/2009 | US20090062139 Phytases, nucleic acids encoding them and methods for making and using them |
| 03/05/2009 | US20090061511 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/05/2009 | US20090061510 Vectors, eukaryotic cells |
| 03/05/2009 | US20090061480 Nucleotide sequence encoding a modulator of nf-kb |
| 03/05/2009 | US20090061452 Polymorphisms in the human genes for OCT 1 and their use in diagnostic and therapeutic applications |
| 03/05/2009 | US20090061048 Delivery and controlled release of encapsulated lipophilic nutrients |
| 03/05/2009 | US20090061031 Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus |
| 03/05/2009 | US20090061014 Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme |
| 03/05/2009 | US20090061009 Composition and Method of Treatment of Bacterial Infections |
| 03/05/2009 | US20090061008 Fiber/granule complex for treatment of the gi tract |
| 03/05/2009 | US20090061006 Layered Nanoparticles for Sustained Release of Small Molecules |
| 03/05/2009 | US20090061002 Calcium phospate based delivery of growth and differentiation factors to compromised bone |
| 03/05/2009 | US20090061000 Pharmaceutical formulation use 030 |
| 03/05/2009 | US20090060999 Protein formulation |
| 03/05/2009 | US20090060991 Glutathione based delivery system |
| 03/05/2009 | US20090060988 Nell-1 enhanced bone mineralization |
| 03/05/2009 | US20090060982 Methods and devices for the sustained release of multiple drugs |
| 03/05/2009 | US20090060978 Resorbable barrier micro-membranes for attenuation of scar tissue during healing |
| 03/05/2009 | US20090060977 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| 03/05/2009 | US20090060976 Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
| 03/05/2009 | US20090060971 Methods of treating a trauma or disorder of the knee joint by local administration and sustained-delivery of a biological agent |
| 03/05/2009 | US20090060970 Compositions and methods of administering paclitaxel with other drugs using medical devices |
| 03/05/2009 | US20090060956 Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria |
| 03/05/2009 | US20090060947 Immunological compositions |
| 03/05/2009 | US20090060940 Compositions and methods for treating psoriasis by ganoderma lucidum (Reishi) polysaccharides |
| 03/05/2009 | US20090060931 Pharmaceutical composition for treating or preventing ovarian cancer |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060925 Rage Fusion Proteins and Methods of Use |
| 03/05/2009 | US20090060917 methyl [2-hydroxy-5-[1-hydroxy-2-[[(2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-phenyl] carbamate; water-stable, long acting beta 2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like |